EXPE vs VTGN · P/E 20, rev $7.74B vs rev $1.3M
Expedia Group Inc. (EXPE) versus VistaGen Therapeutics Inc (VTGN) — a side-by-side from cached financials, not a winner call.
Expedia Group Inc. (EXPE) is a travel services company listed on US.
VistaGen Therapeutics Inc (VTGN) is a biotechnology company listed on NASDAQ.
Latest reported EXPE revenue for 2026-06-30 was $7.74B. Net income was $872.0M. EXPE currently screens at market cap $21.71B and trailing P/E 20.4.
Latest reported VTGN revenue for 2026-03-31 was $1.3M. Net income was -$69.7M. Revenue was up 161.1% from 2025-03-31 to 2026-03-31. VTGN currently screens at market cap $28.1M.
EXPE currently screens at market cap $21.71B and trailing P/E 20.4. VTGN currently screens at market cap $28.1M.
Not investment advice. Open the EXPE and VTGN stock pages for the full models.
Not investment advice.